LISINOPRIL
- Product NDC
- 55700-558
- 11-digit product format
- 557000558
- Labeler code
- 55700
- Product ID
- 55700-558_54cae4f4-6bfe-4697-8ed4-56f6fa8f97a2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lake Erie Medical DBA Quality Care Products LLC
- Application
- ANDA076164
- Marketing category
- ANDA
- Marketing start
- 2011-11-01
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 30 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55700-558-30 | 2025-01-09 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
| 55700-558-60 | 2025-01-09 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
| 55700-558-90 | 2025-01-09 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
| 55700-558-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
| 55700-558-60 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
| 55700-558-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5252-a910-e053-dadaa90a0b85 | e92e8769-9eb3-4622-8710-e70e2e02b92e |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55700-558-30 | EA - Each | 55700-558 | 831163e9-1b17-4afa-9205-c3e3b1d7c5e8 | 1 | 2017-11-06 |
| 55700-558-90 | EA - Each | 55700-558 | 1e0be11e-0aa7-4332-b74b-2f010e26b46b | 1 | 2017-11-06 |